About Lystra Pharma Private Limited
Data last updated:
Lystra Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 11 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2020PTC136305.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Pushparani Gollapalli and Mary Margaret Gollapalli.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 1/9 N.S.K. Tower Subagiri Nagar Thundalam, Chennai, Tamil Nadu, India – 600077.
As per the financials filed for FY 2024, the company reported a revenue of ₹55.61 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹9.15 Lakh (net margin 16.5%) and EBITDA of ₹14.2 Lakh (EBITDA margin 25.5%). Revenue has grown at a compounded annual rate (CAGR) of 119% over three years.
The company is associated with 1 brand: Lystra Pharma.
For more details, the company can be reached via its website lystrapharma.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered AddressNo 1/9 N.S.K. Tower Subagiri Nagar Thundalam, Chennai, Tamil Nadu, India – 600077
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Lystra Pharma Private Limited
The main business activity of Lystra Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Lystra Pharma Private Limited FY 2025 filings available
Lystra Pharma Private Limited reported revenue of ₹55.61 Lakh (up 240% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Lystra Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 119% over three years, including 240% growth in the latest year. EBITDA rose 194% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Lystra Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹14.2 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.15 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Lystra Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 25.5% | •••• | •••• | •••• |
| Net Profit Margin | 16.5% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lystra Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Lystra Pharma Private Limited
Lystra Pharma Private Limited is compared with the companies closest to it by revenue in the Ecommerce and Internet industry (Healthcare Products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Justmed Pharmacy Private Limited | ₹61.71 Lakh (FY 2023) | •••• | •••• | -70.0% | •••• | New Delhi, Delhi, India |
| Dame Health Associates Private Limited | ₹61.44 Lakh (FY 2024) | •••• | •••• | 228.0% | •••• | Kolkata, West Bengal, India |
| My Nutrition Health & Wellness India Private Limited | ₹59.53 Lakh (FY 2023) | •••• | •••• | -90.0% | •••• | New Delhi, Delhi, India |
| Health1 Patron Private Limited | ₹56.4 Lakh (FY 2025) | •••• | •••• | 155.0% | •••• | New Delhi, Delhi, India |
| Balanced Foods Private Limited | ₹56.26 Lakh (FY 2024) | •••• | •••• | -13.0% | •••• | Lonavala, Maharashtra, India |
| Lystra Pharma Private Limited this company | ₹55.61 Lakh (FY 2024) | •••• | •••• | 240.0% | •••• | Chennai, Tamil Nadu, India |
| Kaanish Lifesciences Private Limited | ₹55.28 Lakh (FY 2025) | •••• | •••• | -15.0% | •••• | Greater Noida, Uttar Pradesh, India |
| Manor Rama Care Private Limited | ₹55.14 Lakh (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Piiu Healthcare Products Private Limited | ₹53.95 Lakh (FY 2024) | •••• | •••• | -48.0% | •••• | Delhi, India |
| Charis Remedies Private Limited | ₹53.82 Lakh (FY 2025) | •••• | •••• | 40.0% | •••• | Athirampuzha, Kerala, India |
| Paedicon Biotech Private Limited | ₹53.23 Lakh (FY 2025) | •••• | •••• | -26.0% | •••• | Farrukhabad, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Lystra Pharma by revenue in the Ecommerce and Internet industry (Healthcare Products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Lystra Pharma Private Limited
Lystra Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pushparani Gollapalli Also directs: Giglobus India Private Limited | Director | 01 Jan 2022 | 4 Years 9 Months | Current |
| Mary Margaret Gollapalli | Director | 11 Jul 2020 | 6 Years 2 Months | Current |
| Manoj Kumar Gollapalli | Director | 11 Jul 2020 | 6 Years 2 Months | Current |
Charges & Borrowings of Lystra Pharma Private Limited
Lystra Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Lystra Pharma Private Limited
Lystra Pharma operates one associated brand: Lystra Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers innovative pharmaceutical, nutraceutical, and health supplements with safe delivery in India. | lystrapharma.com |
Employees and EPFO Compliance at Lystra Pharma Private Limited
Employment history and EPFO contributions of people linked to Lystra Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Lystra Pharma Private Limited
Lystra Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Pushparani Gollapalli was appointed as Director on 01 Jan 2022.
Credit Ratings, Litigation & Regulatory Alerts for Lystra Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lystra Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lystra Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lystra Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lystra Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lystra Pharma Private Limited
Lystra Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in specialty, within the trading industry. It was incorporated on 11 July 2020 (6+ years old) and is registered under CIN U51909TN2020PTC136305.
Lystra Pharma reported revenue of ₹55.61 Lakh for FY 2024 (up 240% YoY).
Lystra Pharma has 3 current directors:
- Pushparani Gollapalli - Director
- Mary Margaret Gollapalli - Director
- Manoj Kumar Gollapalli - Director
Lystra Pharma reported a net profit of ₹9.15 Lakh (net margin 16.5%) and EBITDA of ₹14.2 Lakh (EBITDA margin 25.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Lystra Pharma is 119% over three years. In the latest year (FY 2024) revenue rose 240%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Lystra Pharma is U51909TN2020PTC136305. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lystra Pharma was incorporated on 11 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Lystra Pharma by revenue are Justmed Pharmacy Private Limited, Dame Health Associates Private Limited, My Nutrition Health & Wellness India Private Limited, Health1 Patron Private Limited, Balanced Foods Private Limited and 5 more, all in the Ecommerce and Internet industry (Healthcare Products).
Pushparani Gollapalli was appointed as Director on 01 Jan 2022. Manoj Kumar Gollapalli was appointed as Director on 11 Jul 2020. Mary Margaret Gollapalli was appointed as Director on 11 Jul 2020.
Yes, Lystra Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Lystra Pharma can be reached through the website lystrapharma.com. Its registered office is in Chennai, Tamil Nadu, India.